Nom du produit:5-Bromo-3-cyclobutyl-1H-1,2,4-triazole
IUPAC Name:5-bromo-3-cyclobutyl-1H-1,2,4-triazole
- CAS：1199215-81-0
- Formule moléculaire：C6H8BrN3
- Pureté：95%
- Numéro de catalogue：CM275741
- Poids moléculaire：202.06
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:1199215-81-0
- Formule moléculaire:C6H8BrN3
- Point de fusion:-
- Code SMILES:BrC1=NC(C2CCC2)=NN1
- Densité:
- Numéro de catalogue:CM275741
- Poids moléculaire:202.06
- Point d'ébullition:
- N° Mdl:
- Stockage:
Category Infos
- Triazoles
- Triazole refers to a heterocyclic compound with the molecular formula C2H3N3, which has a five-membered ring consisting of two carbon atoms and three nitrogen atoms. Neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease already affect many people around the world, and these numbers are increasing rapidly. Treatment for these disorders is often aimed at relieving symptoms and has no cure. Research on new molecules is underway, and heterocyclic compounds have important pharmacological implications. Triazoles and tetrazoles are emerging as new molecules in this field.
- Cyclobutanes
- The molecular structure of cyclobutane has four carbon atoms, and its four carbon atoms are not in the same plane, which is the folded conformation of cyclobutane. Cyclobutane itself is not of commercial or biological interest, but more complex derivatives are important in biology and biotechnology. Currently, nine FDA-approved drugs contain the cyclobutane structure. From the perspective of therapeutic areas, cyclobutyl drugs are mainly distributed in popular areas such as tumors, neurological diseases, infectious diseases, endocrine and metabolic diseases.
Recherche 
+86 21 5895 0110 
